(SUMO)-wrestling with rituximab

Blood. 2022 May 5;139(18):2728-2730. doi: 10.1182/blood.2022015912.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Immunologic Factors* / therapeutic use
  • Killer Cells, Natural
  • Macrophages
  • Rituximab / therapeutic use
  • Sumoylation*

Substances

  • Immunologic Factors
  • Rituximab